Is Pfizer Stock A Better Pick Over This Pharmaceuticals Bellwether?
- Friday, December 16, 2022, 7:17
- Market
- Add a comment
We believe that Pfizer stock (NYSE: PFE) is currently a better pick than its peer, Johnson & Johnson stock (NYSE: JNJ), given its relatively lower valuation of 3.1x trailing revenues, compared to 4.9x for J&J.
About the Author
admin123 has written 23527 stories on this site.
